NGL CLEANING GmbH
Medical Technology · Borken
NGL CLEANING GmbH is a medical technology company based in Borken, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
NGL CLEANING GmbH Address & Contact
NGL CLEANING GmbH at a Glance
NGL CLEANING GmbH is a renowned manufacturer and provider of cleaning and hygiene products for the medical and pharmaceutical industry based in Borken, North Rhine-Westphalia. The company was founded in 2010 and has since made a name for itself, particularly through the development of innovative cleaning and disinfectant solutions as well as the provision of cleaning systems for the hygienic preparation of medical products and pharmaceutical products. The founding of NGL CLEANING GmbH was a response to the growing demand for high-quality hygiene solutions in an ever-evolving healthcare sector.
Services and Products
NGL CLEANING offers a variety of specific products, including cleaning and disinfectant agents designed for the automatic and manual preparation of medical products. Notably, the innovative solutions for risk-minimized hygiene in facilities such as Central Sterilization Supply Departments (CSSD), laboratories, and pharmaceutical production are emphasized. In addition to conventional cleaning and disinfectant agents, NGL CLEANING also has systems for cleaning validation and residue analysis in its portfolio. These products are certified according to the latest European standards (EN) and meet the strict regulations of medical technology mandated by the European Union and national health authorities. Thus, NGL CLEANING significantly contributes to safety and quality in healthcare.
Location Borken / North Rhine-Westphalia
Borken, located in the picturesque Münsterland, provides NGL CLEANING with a strategically advantageous location near the Dutch border. This cross-border position in the Euregio Rhine-Waal allows the company to maintain close relationships with clinics, pharmaceutical companies, and CSSD departments on both the German and Dutch sides. The region is characterized by a dynamic economic structure in the healthcare and pharmaceutical sector, which offers NGL CLEANING additional opportunities to market its products and services. The location plays an important role in promoting regional innovations in medical technology and hygiene.
Special Features and Innovation Strength
NGL CLEANING stands out due to its strong commitment to research and development in the field of medical technology. The company continuously invests in innovative technologies to develop products that meet the latest scientific findings. This particularly includes the development of products with environmentally friendly ingredients as well as biodegradable formulations that meet sustainability requirements in the healthcare sector. The quality and effectiveness of the products are regularly verified through internal and external laboratory tests, allowing NGL CLEANING to consistently maintain high standards.
Regulatory Classification
The products of NGL CLEANING are subject to strict regulatory requirements. The company is certified according to ISO 13485, a standard specifically developed for manufacturers of medical products, ensuring that their products consistently meet the highest quality standards. In addition, all disinfectants are classified and approved in accordance with European chemical regulations (REACH and CLP), promoting the market acceptance of the products. Memberships in relevant professional associations also demonstrate compliance with applicable legal frameworks and strengthen the company's market position.
Importance for the Region
NGL CLEANING GmbH has contributed not only to the improvement of hygiene standards in the medical and pharmaceutical industry but also to regional economic development, thanks to its impressive products and services. The company creates jobs not only in Borken but throughout the region and cooperates with many local businesses, particularly in the supply sector. This strengthens the local economy and promotes the innovative capacity of the region. The expertise and commitment of NGL CLEANING in medical technology also represent an important contribution to ensuring healthcare provision in the region and beyond.
More medical technology companies: Overview of Medical Technology | Medical Technology North Rhine-Westphalia | Pharmaceutical Companies
Frequently asked questions about NGL CLEANING GmbH
What does NGL CLEANING GmbH do?
NGL CLEANING GmbH is a company in the medical technology sector based in Borken. The company develops, produces or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is NGL CLEANING GmbH located?
NGL CLEANING GmbH is headquartered in Borken.
In which area of medical technology is NGL CLEANING GmbH active?
NGL CLEANING GmbH is active in the medical technology sector and offers solutions for medical facilities, clinics and practices. You can find the exact areas of focus on the company's website.
NGL CLEANING GmbH on social media
More Medical Technology in Borken
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.